3-Butylidenephthalide-d8 13699 [6]-gingerol treatment is shown to

[6]-gingerol treatment is shown to restore impaired intestinal barrier function and to suppress proinflammatory responses in DSS-treated Caco-2 monolayers

InChi: InChI=1S/C11H13NO3/c1-8(13)12-10(11(14)15)7-9-5-3-2-4-6-9/h2-6

InChi: InChI=1S/C90H130N28O29/c1-44(2)28-65(89(146)147)116-78(135)54(14-9-10-26-91)107-79(136)56(20-23-67(93)121)109-84(141)61(31-49-36-96-41-101-49)113-86(143)63(33-51-38-98-43-103-51)115-88(145)73(45(3)4)118-81(138)58(22-25-70(125)126)110-82(139)59(30-48-16-18-52(120)19-17-48)105-68(122)39-100-76(133)66(40-119)117-87(144)64(35-72(129)130)114-85(142)62(32-50-37-97-42-102-50)112-77(134)55(15-11-27-99-90(94)95)108-83(140)60(29-47-12-7-6-8-13-47)111-80(137)57(21-24-69(123)124)106-74(131)46(5)104-75(132)53(92)34-71(127)128/h6-8

connective tissue growth factor [CTGF] and fibroblast growth factor [FGF2])

which might be revealed by combined action of depolarization and activation of nAChRs

3-Butylidenephthalide-d8 13699 [6]-gingerol treatment is shown toProduct information CAS Number: 1795142 65 2 Molecular Weight: 196. 27 Formula: C12H12O2 Chemical Name: (3Z) 3 [(1,2,2,3,3,4,4,4 H)butylidene] 1,3 dihydro 2 benzofuran 1 one Smiles: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H]) C( [2H])=C1\OC(=O)C2=CC=CC=C2\1 InChiKey: WMBOCUXXNSOQHM IKGHHJFWSA N InChi: InChI=1S C12H12O2 c1 2 3 8 11 9 6 4 5 7 10(9)12(13)14 11 h4 8H,2 3H2,1H3 b11 8 i1D3,2D2,3D2,8D Technical Data Appearance: Solid Power Purity: 98% (or